Ratan Tata-backed Axio Biosolution Launches MaxioCel, Cutting-Edge Innovation in Advance Wound Care

Introducing the latest innovation in wound care, Axio Biosolutions, a biotech startup backed by Ratan Tata's RNT Capital, has launched MaxioCel, a next generation wound care dressing made of chitosan. Dr. V. S. Bedi, Director and Chairman, Vascular and Endovascular Department, Sir Gangaram Hospital, launched MaxioCel